1. Home
  2. Analysis
  3. Rosuvastatin-calcium
  4. Pemphigus

Rosuvastatin calcium and Pemphigus - a phase IV clinical study of FDA data

Summary:

Pemphigus is reported as a side effect among people who take Rosuvastatin calcium (rosuvastatin calcium), especially for people who are male, 60+ old, also take Prednisone, and have Non-hodgkin's lymphoma.

The phase IV clinical study analyzes which people have Pemphigus when taking Rosuvastatin calcium. It is created by eHealthMe based on reports of 24,757 people who have side effects when taking Rosuvastatin calcium from the FDA, and is updated regularly.

What is Rosuvastatin calcium?

Rosuvastatin calcium has active ingredients of rosuvastatin calcium. It is often used in high blood cholesterol. eHealthMe is studying from 25,354 Rosuvastatin calcium users. Check the latest studies of Rosuvastatin calcium.

What is Pemphigus?

Pemphigus (any of several acute or chronic skin diseases characterized by groups of itching blisters) is found to be associated with 304 drugs and 304 conditions by eHealthMe. Check the latest studies of Pemphigus.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 26, 2026

24,757 people reported to have side effects when taking Rosuvastatin calcium.
Among them, 51 people (0.21%) have Pemphigus.

Could Rosuvastatin calcium cause Pemphigus?

Among these 51 people:

What is the gender of people who have Pemphigus when taking Rosuvastatin calcium? *

  • female: 29.73 %
  • male: 70.27 %

What is the age of people who have Pemphigus when taking Rosuvastatin calcium? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 8.82 %
  • 50-59: 5.88 %
  • 60+: 85.29 %

What are other drugs people take besides Rosuvastatin calcium? *

  1. Prednisone: 35 people, 68.63%
  2. Tylenol: 26 people, 50.98%
  3. Benadryl: 26 people, 50.98%
  4. Mycophenolate Mofetil: 24 people, 47.06%
  5. Methylprednisolone Sodium Succinate: 23 people, 45.10%
  6. Aspirin: 20 people, 39.22%
  7. Risedronate Sodium: 18 people, 35.29%
  8. Olmesartan Medoxomil: 18 people, 35.29%
  9. Canagliflozin: 18 people, 35.29%
  10. Nifedipine: 18 people, 35.29%

What are other side effects people have besides Pemphigus? *

  1. Blood Pressure Fluctuation: 30 people, 58.82%
  2. Blood Pressure Systolic Increased: 30 people, 58.82%
  3. Mouth Ulcers: 28 people, 54.90%
  4. Blood Glucose Increased: 27 people, 52.94%
  5. Oxygen Saturation Decreased: 23 people, 45.10%
  6. Heart Rate Increased: 23 people, 45.10%
  7. High Blood Pressure: 21 people, 41.18%
  8. Blood Pressure Systolic Abnormal: 12 people, 23.53%
  9. Skin Ulcer: 11 people, 21.57%
  10. Body Temperature Decreased: 11 people, 21.57%

What are the existing conditions these people have? *

  1. Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 10 people, 19.61%
  2. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 3 people, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Rosuvastatin calcium and have Pemphigus?

- Check whether Pemphigus is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Rosuvastatin calcium:

Pemphigus treatments and more:

How severe was Pemphigus and when was it recovered:

Expand to all the drugs that have ingredients of rosuvastatin calcium:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Rosuvastatin calcium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Pemphigus:

Browse all the conditions that are associated with Pemphigus:

Related publications that referenced our studies

How the study uses the data?

The study uses data from the FDA. It is based on rosuvastatin calcium (the active ingredients of Rosuvastatin calcium) and Rosuvastatin calcium (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.